Concepedia

Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein

Cory R. Trankle, Justin M. Canada, Laura Cei, Nayef Abouzaki, Claudia Oddi‐Erdle, Dinesh Kadariya, Sanah Christopher, Michele Mattia Viscusi, Marco Giuseppe Del Buono, Michael C. Kontos,

The American Journal of Cardiology · 2018 · 74 citations · 11 references

DOIFull text

Open access

Concepts

References

11

2013 ACCF/AHA Guideline for the Management of Heart Failure

Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt et al. · Journal of the American College of Cardiology · 2013 · 12.6K citations

, , +14

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 9.1K citations · Full text

, , +17

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

Paul M. Ridker, Tom Thurén, Andrew Zalewski et al. · American Heart Journal · 2011 · 793 citations · Full text

, , +14

Peak aerobic capacity predicts prognosis in patients with coronary heart disease

Steven J. Keteyian, Clinton A. Brawner, Patrick D. Savage et al. · American Heart Journal · 2008 · 412 citations

, , +14

Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure

Benjamín W. Van Tassell, Justin M. Canada, Salvatore Carbone et al. · Circulation Heart Failure · 2017 · 236 citations · Full text

, , +17